Evidence map›Paper›PMID 25550867›Full record

SynthesisInternational journal of clinical and experimental pathology2014

Secondary glaucoma as initial manifestation of ring melanoma: a case report and review of literature.

Manli Zhao, Yalin Mu, Yalong Dang, Yu Zhu

Open access · greenAbstract readCase ReportsSystematic Review
In one paragraph

Synthesis in International journal of clinical and experimental pathology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Isolated Ocular Sarcoidosis Mimicking Ring Melanoma.Ocular oncology and pathology · 2020
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Manli ZhaoDepartment of Ophthalmology, Yellow River Hospital, Henan University of Science and Technology Sanmenxia City, Henan Province, People's Republic of China.
Yalin MuDepartment of Ophthalmology, Yellow River Hospital, Henan University of Science and Technology Sanmenxia City, Henan Province, People's Republic of China.
Yalong DangDepartment of Ophthalmology, Yellow River Hospital, Henan University of Science and Technology Sanmenxia City, Henan Province, People's Republic of China ; Department of Ophthalmology, The First Affiliated Hospital, Zhengzhou University Zhengzhou City, Henan Province, People's Republic of China.
Yu ZhuDepartment of Ophthalmology, The First Affiliated Hospital, Zhengzhou University Zhengzhou City, Henan Province, People's Republic of China.
Henan University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Melanomas account for over 70% of adult malignancies in the eye and occur primarily in the choroid. Melanomas rarely originate in the ciliary body, with an annual incidence of approximately 1.6 cases per million. While the incidence rate of these tumors is low, malignant melanomas metastasize at early stages of disease development and show poor prognoses. Malignant melanomas of the ciliary body are often deeply hidden and have complex clinical manifestations, which are easily misdiagnosed and affect the prognosis. Here, we report a case of monocular ciliary body melanoma in an elderly Asian woman. Using this case as an example, we perform a systematic review of the disease's clinical symptoms, signs, diagnoses, differential diagnoses, treatment and prognosis.

Indexed as

AgedEye EnucleationFemaleGlaucomaHumansMelanomaPrognosisUveal MelanomaUveal Neoplasmsciliary bodyMalignant melanomaring malignant melanomasecondary glaucoma

Identifiers

PMID25550867
PMCPMC4270514
OpenAlexW2337640373

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.